FIRST AND ONLY TREATMENT FOR CHRONIC HYPOPARATHYROIDISM APPROVED IN AUSTRALIA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/16/2026

1. ASML
2. JBHT
3. JNJ
4. PNC
5. ASML:NA
6. UNH
7. SPY
8. NVDA
9. MS
10. BNY

Go back to FIRST AND ONLY TREATMENT FOR CHRONIC HYPOPARATHYROIDISM APPROVED IN AUSTRALIA
Asianada, Inc. (NASDAQ: ASND) Delayed: 268.57 --0 (-0%)
Previous Close $268.57    52 Week High $21.79 
Open $268.57    52 Week Low $11.92 
Day High $268.57    P/E N/A 
Day Low $268.57    EPS $-0.07 
Volume 524